How Analysts Feel About Alcobra Limited Ord (NASDAQ:ADHD) After Decrease in Sellers?

June 20, 2017 - By Linda Rogers

 How Analysts Feel About Alcobra Limited Ord (NASDAQ:ADHD) After Decrease in Sellers?

The stock of Alcobra Limited Ord (NASDAQ:ADHD) registered a decrease of 0.16% in short interest. ADHD’s total short interest was 1.21M shares in June as published by FINRA. Its down 0.16% from 1.21M shares, reported previously. With 246,800 shares average volume, it will take short sellers 5 days to cover their ADHD’s short positions. The short interest to Alcobra Limited Ord’s float is 7.88%.

About shares traded. Alcobra Ltd (NASDAQ:ADHD) has declined 74.73% since June 20, 2016 and is downtrending. It has underperformed by 91.43% the S&P500.

Alcobra Ltd is an Israel-based Biopharmaceutical company. The company has market cap of $32.83 million. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder , a common and morbid neuropsychiatric condition in children and adults. It currently has negative earnings. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse.

Alcobra Ltd (NASDAQ:ADHD) Ratings Coverage

Among 7 analysts covering Alcobra (NASDAQ:ADHD), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Alcobra had 15 analyst reports since August 9, 2015 according to SRatingsIntel. The rating was initiated by Oppenheimer with “Outperform” on Monday, January 25. The stock of Alcobra Ltd (NASDAQ:ADHD) has “Buy” rating given on Thursday, February 4 by Roth Capital. Barclays Capital downgraded the stock to “Underweight” rating in Friday, October 28 report. The firm earned “Hold” rating on Sunday, August 9 by WBB Securities. The firm has “Buy” rating by Jefferies given on Thursday, February 18. WBB Securities upgraded it to “Hold” rating and $1.90 target in Wednesday, November 2 report. The firm earned “Hold” rating on Thursday, September 29 by Cantor Fitzgerald. The firm has “Hold” rating by Jefferies given on Wednesday, January 18. The stock of Alcobra Ltd (NASDAQ:ADHD) has “Hold” rating given on Monday, August 17 by Zacks. The stock has “Buy” rating by Roth Capital on Tuesday, June 21.

More notable recent Alcobra Ltd (NASDAQ:ADHD) news were published by: Globenewswire.com which released: “Alcobra Announces Leadership Update” on May 15, 2017, also Globenewswire.com with their article: “Alcobra Provides Update on Cancellation of Extraordinary Meeting Called by …” published on May 05, 2017, Globenewswire.com published: “Alcobra Mails Proxy Materials for Extraordinary General Meeting of Shareholders” on April 24, 2017. More interesting news about Alcobra Ltd (NASDAQ:ADHD) were released by: Streetinsider.com and their article: “Alcobra Ltd. (ADHD) Enters Cooperation Agreement with Brosh Capital Partners” published on June 12, 2017 as well as Globenewswire.com‘s news article titled: “IMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz …” with publication date: February 24, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.